Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
On April 23, 2026 it came off the FDAs Category 2 do not compound list, and its one of seven peptides the FDAs Pharmacy Compounding Advisory Committee (PCAC) reviews on July 23-24, 2026 for 503A compounding eligibility
Stability is a shared responsibility between the supplier and the researcher
Details and Features: Concentration and Formulation: Each mL of solution contains 1000 mcg of Cyanocobalamin, providing a high-strength treatment option
The pathophysiology of these conditions is likely to be heterogenous, and factors such as altered motility, sensitivity and response to nutrition have been identified as putative underlying mechanisms
US$ 22.88
US$ 25.33
US$ 22.34
US$ 24.24
US$ 27.30
